The SDR Antibody (PAC061762) is a highly specific monoclonal antibody designed for research involving the SDR enzyme, which is implicated in various metabolic pathways and drug metabolism. The antibody, produced using advanced technology, exhibits exceptional reactivity with human samples and is validated for use in immunohistochemistry and ELISA applications. It binds specifically to the SDR enzyme, enabling precise detection and analysis in diverse biological samples, making it an ideal tool for studies in drug development, toxicology, and metabolic disorders.
The SDR enzyme, also known as short-chain dehydrogenase/reductase, plays a crucial role in catalyzing the reduction or oxidation of a wide range of substrates, including steroids, retinoids, and xenobiotics. Its involvement in diverse metabolic processes makes it a valuable target for research into drug metabolism, hormone regulation, and metabolic diseases. Understanding the function of the SDR enzyme is essential for advancing therapeutic strategies and developing novel treatments for metabolic disorders and drug-related toxicity.
Antibody Name:
SDR Antibody (PACO61762)
Antibody SKU:
PACO61762
Size:
50ul
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:500-1:5000
Species Reactivity:
Zebrafish
Immunogen:
Recombinant Zebrafish Short-chain alcohol dehydrogenase protein (1-137AA)
Western Blot. Positive WB detected in: Zebrafish tissue. All lanes: SDR antibody at 3µg/ml. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 34 kDa. Observed band size: 34 kDa.
